525 related articles for article (PubMed ID: 19479684)
1. Reducing the cost of detection of congenital heart disease in fetuses of women with pregestational diabetes mellitus.
Bernard LS; Ramos GA; Fines V; Hull AD
Ultrasound Obstet Gynecol; 2009 Jun; 33(6):676-82. PubMed ID: 19479684
[TBL] [Abstract][Full Text] [Related]
2. The Accuracy and Cost-Effectiveness of Selective Fetal Echocardiography for the Diagnosis of Congenital Heart Disease in Patients with Pregestational Diabetes Stratified by Hemoglobin A1c.
Finneran MM; Ware CA; Kiefer MK; Buschur EO; Foy PM; Thung SF; Landon MB; Gabbe SG
Am J Perinatol; 2019 Oct; 36(12):1216-1222. PubMed ID: 30991442
[TBL] [Abstract][Full Text] [Related]
3. [Importance of "Guidelines for performing fetal cardiac scan" in prenatal screening for fetal congenital heart disease].
Xu Y; Hu YL; Ru T; Gu Y; Yang Y; Dai CY
Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):103-7. PubMed ID: 19570419
[TBL] [Abstract][Full Text] [Related]
4. Expected probability of congenital heart disease and clinical utility of fetal echocardiography in pregnancies with pre-gestational diabetes.
Nassr AA; El-Nashar SA; Shazly SA; White WM; Brost BC
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():121-5. PubMed ID: 27104489
[TBL] [Abstract][Full Text] [Related]
5. Influence of prenatal diagnosis on congenital heart defects.
DeVore GR
Ann N Y Acad Sci; 1998 Jun; 847():46-52. PubMed ID: 9668697
[TBL] [Abstract][Full Text] [Related]
6. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease.
Stümpflen I; Stümpflen A; Wimmer M; Bernaschek G
Lancet; 1996 Sep; 348(9031):854-7. PubMed ID: 8826811
[TBL] [Abstract][Full Text] [Related]
7. Prenatal detection of congenital heart disease at 12-13 gestational weeks: detailed analysis of false-negative cases.
Bottelli L; Franzè V; Tuo G; Buffelli F; Paladini D
Ultrasound Obstet Gynecol; 2023 May; 61(5):577-586. PubMed ID: 36240512
[TBL] [Abstract][Full Text] [Related]
8. Detection of fetal cardiac anomalies: cost-effectiveness of increased number of cardiac views.
Bak GS; Shaffer BL; Madriago E; Allen A; Kelly B; Caughey AB; Pereira L
Ultrasound Obstet Gynecol; 2020 Jun; 55(6):758-767. PubMed ID: 31945242
[TBL] [Abstract][Full Text] [Related]
9. Impact of maternal obesity on fetal cardiac screening: which follow-up strategy is cost-effective?
Bak GS; Shaffer BL; Madriago E; Allen A; Kelly B; Caughey AB; Pereira L
Ultrasound Obstet Gynecol; 2020 Nov; 56(5):705-716. PubMed ID: 31614030
[TBL] [Abstract][Full Text] [Related]
10. Screening fetal echocardiography in diabetic mothers with normal findings on detailed anatomic survey.
Sekhavat S; Kishore N; Levine JC
Ultrasound Obstet Gynecol; 2010 Feb; 35(2):178-82. PubMed ID: 20101639
[TBL] [Abstract][Full Text] [Related]
11. Barriers to prenatal detection of congenital heart disease: a population-based study.
Pinto NM; Keenan HT; Minich LL; Puchalski MD; Heywood M; Botto LD
Ultrasound Obstet Gynecol; 2012 Oct; 40(4):418-25. PubMed ID: 21998002
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of prenatal screening strategies for congenital heart disease.
Pinto NM; Nelson R; Puchalski M; Metz TD; Smith KJ
Ultrasound Obstet Gynecol; 2014 Jul; 44(1):50-7. PubMed ID: 24357432
[TBL] [Abstract][Full Text] [Related]
13. Does a prenatal diagnosis of congenital heart disease alter short-term outcome?
Copel JA; Tan AS; Kleinman CS
Ultrasound Obstet Gynecol; 1997 Oct; 10(4):237-41. PubMed ID: 9383873
[TBL] [Abstract][Full Text] [Related]
14. Why are congenital heart defects being missed?
van Nisselrooij AEL; Teunissen AKK; Clur SA; Rozendaal L; Pajkrt E; Linskens IH; Rammeloo L; van Lith JMM; Blom NA; Haak MC
Ultrasound Obstet Gynecol; 2020 Jun; 55(6):747-757. PubMed ID: 31131945
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of four-dimensional spatiotemporal image correlation echocardiography in the prenatal diagnosis of congenital heart defects.
Bennasar M; Martínez JM; Gómez O; Bartrons J; Olivella A; Puerto B; Gratacós E
Ultrasound Obstet Gynecol; 2010 Oct; 36(4):458-64. PubMed ID: 20549767
[TBL] [Abstract][Full Text] [Related]
16. Extracardiac lesions and chromosomal abnormalities associated with major fetal heart defects: comparison of intrauterine, postnatal and postmortem diagnoses.
Song MS; Hu A; Dyamenahalli U; Chitayat D; Winsor EJ; Ryan G; Smallhorn J; Barrett J; Yoo SJ; Hornberger LK
Ultrasound Obstet Gynecol; 2009 May; 33(5):552-9. PubMed ID: 19350566
[TBL] [Abstract][Full Text] [Related]
17. Fetal interrupted aortic arch: 2D-4D echocardiography, associations and outcome.
Volpe P; Tuo G; De Robertis V; Campobasso G; Marasini M; Tempesta A; Gentile M; Rembouskos G
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):302-9. PubMed ID: 20069674
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of prenatal screening methods for congenital heart defects in pregnancies conceived by in-vitro fertilization.
Chung EH; Lim SL; Havrilesky LJ; Steiner AZ; Dotters-Katz SK
Ultrasound Obstet Gynecol; 2021 Jun; 57(6):979-986. PubMed ID: 32304621
[TBL] [Abstract][Full Text] [Related]
19. [Fetal echocardiography in diagnosing congenital heart disease prenatally: a multicenter clinical study].
Zhu RY; Gui YH; Li LC; Chen RY; Sun L; Chang C
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):764-9. PubMed ID: 17229382
[TBL] [Abstract][Full Text] [Related]
20. [Prenatal diagnosis of heart defects and associated chromosomal aberrations].
Chaoui R; Körner H; Bommer C; Göldner B; Bierlich A; Bollmann R
Ultraschall Med; 1999 Oct; 20(5):177-84. PubMed ID: 10595385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]